Hexcel (HXL) Q1 2026 Earnings Call Transcript

Hexcel reported Q1 sales of $502 million, up 10% reported and 8.8% in constant currency, with adjusted EPS of $0.59, gross margin improving to 26.9% from 22.4%, and adjusted EBITDA rising 26% to $107 million. Commercial aerospace drove the beat, while defense sales declined 6.9% from divestitures; management reaffirmed full-year 2026 EPS guidance of $2.10 to $2.30 despite an 80 bps FX headwind. Liquidity improved with a $750 million revolver extended to 2031, and the company completed an accelerated share repurchase and declared a $0.18 quarterly dividend.

Analysis

The real signal here is not the beat; it’s that the revenue mix is finally turning into self-reinforcing operating leverage while the company is still under-earning its capacity. The biggest second-order effect is on competitors and suppliers: as Hexcel reopens lines and hires ahead of demand, it is effectively reclaiming share of wallet from less vertically integrated composites vendors that can’t match qualification depth or pricing discipline. The stronger Boeing and wide-body mix also suggests the recovery is becoming less Airbus-dependent, which matters because that lowers the probability that one OEM rate hiccup derails the whole demand bridge.

The margin setup is more nuanced than headline gross margin expansion implies. A chunk of Q1 uplift came from timing and inventory accounting, so the market should not extrapolate the full 400+ bp spread into subsequent quarters; however, the underlying driver is still real because fixed-cost absorption is improving before the next wave of hiring and line restarts fully hits the P&L. That means the next 2-3 quarters are likely to be choppier on EPS than sales, especially as FX headwinds, start-up costs, and elevated R&D partially offset the manufacturing leverage.

The defense side is the underappreciated catalyst: missile flow-through is delayed, but the order book timing suggests a visible inflection into 2H26 rather than a generic long-term story. If that ramp shows up while commercial remains stable, the market may have to re-rate HXL as a quasi-scarcity asset in advanced materials with both civil and military content, rather than a pure aerospace beta name. The biggest consensus miss is probably that leverage is not just a balance-sheet issue; it is the gating item for buybacks, M&A, and any multiple expansion tied to capital return.

Near term, the setup supports the stock on guidance credibility, but the asymmetry is not great if Airbus A320 constraints worsen or if FX and energy costs persist longer than hedges cover. The cleaner trade is on relative performance versus OEMs and industrial cyclicals, not an outright chase into a good quarter.

Key Decisions for Investors

• Long HXL on a 1-3 month horizon on pullbacks after the opening reaction; use the stock’s guidance reaffirmation and 2H defense inflection as the thesis, but size modestly because Q2/Q3 EPS can be noisy from FX and start-up costs.
• Pair trade: long HXL / short BA or MAX into the next 6-8 weeks. HXL benefits from production normalization regardless of final deliveries, while OEM execution risk and rate volatility create a cleaner hedge on the aerospace cycle.
• Sell downside in HXL via 3-6 month put spreads if implied volatility stays elevated. The near-term risk is more about cadence than collapse, and the company’s liquidity extension plus liquidity-light buyback posture should limit tail risk.
• If already long, trim into strength above the post-earnings move and redeploy only if leverage trends toward sub-2.0x by year-end. That is the key catalyst for renewed buybacks and a higher multiple, so capital should be reserved for that inflection.
• Watch for 2H26 defense order conversion and A350 rate commentary; if both improve simultaneously, add to HXL and consider a longer-dated call spread to capture a rerating before buyback capacity returns.